Allergy And Immunology Market to Grow with a CAGR of 5.25% through 2029
Rising incidence of
allergies and immunological disorders and increasing awareness and education are
factors driving the Global Allergy and Immunology Market in the forecast period 2025-2029
According to
TechSci Research report, “Allergy And Immunology Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029”,
the Global Allergy And Immunology Market stood at USD 2.52 Billion in 2023 and
is anticipated to grow with a CAGR of 5.25% in the forecast period, 2025-2029.
The
Global Allergy and Immunology Market is experiencing a surge in growth, driven
by various factors that are reshaping the landscape of healthcare and
diagnostics. As the prevalence of allergies and immune system disorders
continues to rise globally, the market is witnessing unprecedented demand for
innovative diagnostics, therapeutics, and preventive measures. The primary driver of the global market is the
escalating prevalence of allergies and immunological disorders. Factors such as
environmental pollution, changing lifestyles, and genetic predispositions
contribute to the increasing incidence of conditions like allergic rhinitis,
asthma, and autoimmune diseases. This surge in patient numbers is fueling the
demand for advanced diagnostic tools and effective treatment options.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Allergy And Immunology Market”
Technological
advancements in diagnostic tools have revolutionized the field of allergy and
immunology. From traditional skin tests to sophisticated molecular diagnostics,
the market is witnessing a paradigm shift towards more accurate and efficient
diagnostic methods. The integration of artificial intelligence and machine
learning in diagnostic procedures is further enhancing the precision and speed
of identifying allergies and immunological disorders.
There
has been a significant increase in public awareness regarding allergies and
immunological disorders. This heightened awareness, coupled with efforts by
healthcare organizations and advocacy groups, has led to early detection and
diagnosis. Patients are now more informed about the importance of seeking
medical attention for symptoms related to allergies and immune system
dysregulation, thereby driving the demand for healthcare services and products.
Pharmaceutical and biotechnology
companies are investing heavily in research and development to bring forth
innovative therapies and treatment options. The focus is on developing targeted
therapies that not only alleviate symptoms but also address the underlying
causes of allergies and immunological disorders. The continuous influx of novel
products into the market is contributing to its growth and dynamism.
The
globalization of healthcare services has facilitated the exchange of medical
knowledge and expertise worldwide. This has led to the standardization of
diagnostic criteria and treatment protocols, ensuring a more uniform approach
to managing allergies and immunological disorders. The accessibility of
advanced treatments across geographies is driving market growth as patients
seek the best available care.
The Global Allergy
And Immunology Market is segmented into treatment type, allergy type,
distribution channel and company.
Based
on distribution channel,
the Hospital Pharmacy segment has emerged as the predominant market leader. Hospital
pharmacies are uniquely positioned to foster collaborative research and
development efforts. The proximity to healthcare professionals, researchers,
and patients allows pharmacists to actively engage in the identification of
emerging trends and unmet medical needs in the field of allergy and immunology.
This collaborative approach has fueled the development of novel treatments,
including biologics, immunotherapies, and precision medicine. Hospital pharmacies play a crucial role in ensuring
the accessibility of allergy and immunology treatments to patients. They serve
as key intermediaries between healthcare providers, pharmaceutical
manufacturers, and patients, ensuring that medications are available and
dispensed appropriately. Additionally, hospital pharmacists contribute to
patient education, providing valuable information on medication adherence,
potential side effects, and lifestyle modifications to manage allergies
effectively.
Based on region,
North America segment is expected to grow during the forecast
period. North America has witnessed a significant rise in the
prevalence of allergic conditions and immunologic disorders over the past few
decades. Factors such as environmental changes, genetic predisposition, and
lifestyle modifications contribute to the increasing incidence of allergies. As
a result, the demand for effective treatments and therapies has surged,
prompting the development of new drugs and interventions to address the growing
health concerns.
The Asia Pacific
region is experiencing rapid market growth. Asia Pacific’s pharmaceutical
companies and research institutions actively engage in collaborations and
partnerships to leverage each other's strengths and expertise. These strategic
alliances facilitate the pooling of resources, sharing of knowledge, and
acceleration of research and development efforts. The synergy created through
collaborations contributes to the rapid advancement of allergy and immunology
solutions in the market.
Major companies
operating in Global Allergy And Immunology Market are:
- ALK-Abello A/S
- Teva Pharmaceutical Industries
- AbbVie Inc.
- Stallergenes Greer PLC
- Allergy Therapeutics
- Sanofi SA
- Anacor Pharmaceuticals Inc.
- Novartis International AG
- AstraZeneca
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- GlaxoSmithKline PLC
- Mylan N.V.
Download Free Sample Report
Customers can
also request 10% free customization in this report
“The
Global Allergy and Immunology Market is propelled by a convergence of factors
ranging from technological advancements to increased awareness and
globalization of healthcare. As the market continues to evolve, stakeholders
must remain vigilant to emerging trends and opportunities. With ongoing
research and development, coupled with a commitment to patient-centered care,
the market is poised to address the rising challenges posed by allergies and
immunological disorders, providing hope for improved quality of life for
millions around the world.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Allergy And Immunology Market By Treatment Type
(Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), Tablets,
Drops), By Allergy Type (Allergic
Rhinitis, Allergic Asthma, Other Allergies), By Distribution Channel (Hospital
Pharmacy, Retail Pharmacy, Online Pharmacy), By
Region, By Competition Forecast & Opportunities, 2019-2029F”,
has evaluated the future growth potential of Global Allergy And Immunology
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Allergy And
Immunology Market.
Contact
TechSci Research
LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
Tel:
+1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com